Visit https://www.peervoice.com/XMC860 to view the entire programme with slides. After completing “Keeping an Eye on the Kidney When Optimizing Anticoagulation Therapy in Patients With Diabetes and Atrial Fibrillation”, participants will be able to: Describe the link between diabetes and AF and the increased risk of renal impairment in patients with diabetes; Discuss the different DOACs available and their safety and efficacy in patients with diabetes, AF, and renal impairment, versus warfarin; Identify DOACs’ role in preventing outcomes in patients with diabetes, AF, and renal impairment.